Park et al. reported a gelatin hydrogel for the sustained release of PTH to rescue the therapeutic potential of tonsil-derived mesenchymal stem cells (TDMSCs) for hypoparathyroidism [110]. This evidence concerns the gene PTH and hypoparathyroidism.